Recruiting

NCT Number: NCT07349251

Normal Hemostasis Values in Premature Infants

This study aims to retrospectively determine, in a large cohort of apparently healthy children born before 37 weeks of gestation, the expected values of certain hemostasis parameters from birth to 18 months (when they start walking), and to determine whether or not they differ from those of full-term infants.

Recruiting

Interested in participating?

Request Info

Key information

Conditions

Premature Infant, Hemostasis Female Urogenital Diseases and Pregnancy Complications Obstetric Labor Complications Obstetric Labor, Premature Pregnancy Complications Premature Birth Urogenital Diseases

Age range

0 month–18 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Laboratoire d'Hématologie - CHU de Strasbourg - France

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Agathe HERB, PharmD

CONTACT

[email protected]

33 3 88 12 75 53

Agathe HERB, PharmD

PRINCIPAL_INVESTIGATOR

Claire Bopp, MD

SUB_INVESTIGATOR

David Millard, MD

PRINCIPAL_INVESTIGATOR

Jordan Wimmer, MD

SUB_INVESTIGATOR

Laurent Sattler, MD

SUB_INVESTIGATOR

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Patients aged 18 months or younger for whom a sample was sent to the Hematology Laboratory at Strasbourg University Hospital for measurement of a hemostasis parameter

Exclusion criteria

Patients with incomplete data
Patients with a congenital hemostasis disorder (hemophilia A or B, von Willebrand disease), a coagulopathy, or hepatocellular insufficiency

Treatment and study plan

Primary outcomes

Normal hemostasis values in premature infants

Time frame: Up to 6 years

Normal hemostasis values in premature infants will be determined according to the gestational age at birth

Study contacts

Contact information is provided by the study sponsor or research team.

Agathe HERB, PharmD

CONTACT

[email protected]

33 3 88 12 75 53

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: PRHEMO

Important dates

Study start: 2025
Primary completion: 2031
Study completion: 2031
First posted: Jan 16, 2026
Registry last updated: Jan 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting